• Needham PROSE Clinic
  • Find a PROSE Clinic
  • Donate
  • Contact Us
  • Patient Care
    • PROSE Treatment
    • Find a PROSE Clinic
    • Conditions We Treat
    • Patient Stories
    • Patient Resources
    • Pediatrics
  • Technology
    • Our Products
    • Software Platforms
    • Manufacturing
  • Education
    • Visiting Clinicians
    • FitAcademy International
    • FitAcademy for Residents
    • FitAcademy Immersive
    • Ophthalmology Resident Lectures
  • Research
    • Clinical Trials and R&D Services
    • Research Studies
    • Publications
  • About
    • Our Approach
    • News
    • Our People
    • Our Partners
  • Needham PROSE Clinic
  • Find a PROSE Clinic
  • Donate
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Acanthamoeba Keratitis: A Rare But Serious Eye Infection

December 15, 2025/0 Comments/in Blog Posts/by michele

Acanthamoeba keratitis (AK) is a rare but potentially vision-threatening infection of the cornea—the clear, dome-shaped surface at the front of the eye. While uncommon, it can lead to significant pain, prolonged treatment, and, in severe cases, permanent vision loss if not diagnosed and treated promptly. Contact lens wearers, including scleral lens wearers, make up the majority of cases. It is more likely to affect you if you have an eye infection, a corneal scratch or other eye injury, or are immunocompromised. Eye injuries can leave the cornea more vulnerable, allowing the parasite to enter the cornea.

What Is Acanthamoeba?

Acanthamoeba is a microscopic, free-living amoeba commonly found in the environment, including tap water, lakes, hot tubs, swimming pools, soil, and air. In most situations, it poses no threat to human health. However, when it comes into contact with the eye—particularly a cornea that has been compromised—it can cause a serious infection.

Who Is at Risk?

Although anyone can develop Acanthamoeba keratitis, the majority of cases occur in contact lens wearers. Risk factors include:

  • Rinsing or storing contact lenses in tap water
  • Swimming, showering, or using hot tubs while wearing contact lenses
  • Improper contact lens cleaning or storage
  • Using homemade or non-sterile saline solutions
  • Poor contact lens hygiene or overwearing lenses

Even individuals who follow recommended lens care practices can be at risk, which makes awareness and early detection especially important.

Symptoms to Watch For

Acanthamoeba keratitis often begins with symptoms that resemble more common eye infections, which can delay diagnosis. Key symptoms may include:

  • Severe eye pain
  • Redness and tearing
  • Sensitivity to light (photophobia)
  • Blurred or decreased vision
  • A feeling of something in the eye
  • Excessive tearing or discharge

Because symptoms can worsen over time, early evaluation by an eye care professional is critical if they persist or intensify.

Why Early Diagnosis Matters

AK is difficult to diagnose and treat, and delayed diagnosis increases the risk of corneal scarring, the need for corneal transplantation, and long-term vision impairment. Diagnosis may involve corneal scraping, specialized cultures, confocal microscopy, or advanced imaging techniques. Once identified, treatment often requires a prolonged course of topical antimicrobial medications and close monitoring.

Treatment and Recovery

Treatment for Acanthamoeba keratitis can be lengthy—often lasting several months—and may involve:

  • Topical anti-amoebic medications
  • Pain management strategies
  • Temporary discontinuation of contact lens wear
  • In severe cases, surgical intervention such as corneal transplantation

Recovery varies widely. Some patients regain good vision, while others may experience lasting visual effects despite aggressive treatment. AK can result in permanent scarring, permanent corneal irregularities, and/or vision loss. After the infection is completely cleared, scleral lenses, such as PROSE and BostonSightSCLERAL, may be an option to rehabilitate vision.

Prevention: Simple Steps Make a Big Difference

Preventing Acanthamoeba keratitis largely comes down to proper contact lens hygiene:

  • Never rinse or store lenses in tap water
  • Do not wear contact lenses while swimming or showering
  • Use only sterile, recommended contact lens solutions
  • Replace lens cases regularly
  • Wash and dry your hands thoroughly before handling lenses
  • Follow your eye care provider’s recommendations for lens wear and replacement

image from https://eyewiki.org/Acanthamoeba_Keratitis

 

https://www.bostonsight.org/wp-content/uploads/2025/12/Acanthamoeba_Keratitis.png 406 392 michele /wp-content/uploads/2026/05/bostonsight-logo.svg michele2025-12-15 14:44:432026-06-23 12:13:06Acanthamoeba Keratitis: A Rare But Serious Eye Infection

BostonSight Expands to Europe with BostonSight SCLERAL and FitAcademy

December 10, 2025/0 Comments/in Press Release/by michele

Needham, Mass. – December 10, 2025 – BostonSight® announced today that BostonSight SCLERAL® lenses are now available in Europe through its licensed manufacturer, Conóptica SL, a subsidiary of Hecht Contactlinsen. Eyecare practitioners in Spain, Portugal, and Morocco can now bring BostonSight’s data-driven lens technology to their patients. Conóptica has been providing gas permeable lenses, eyecare equipment, and training to eye care practitioners in Spain and beyond since 1963.

“We are committed to providing eyecare practitioners around the world with the best specialty lens technology,” said Sara Yost, BostonSight President and CEO. “Our partnership with Conoptica brings us one step closer to ensuring that everyone who needs a scleral lens, anywhere, will have access to best-in-class treatments and care.”

In addition, BostonSight held FitAcademy® International in Spain on November 21-22, 2025, bringing the FitAcademy brand of education to specialty lens fitters in  Europe. The program, held in Barcelona, had more than 70 attendees and a curriculum delivered by top faculty from the region. Led by BostonSight’s Chief Innovation and Education Officer, Karen G. Carrasquillo, OD, PhD, FAAO, FSLS, FBCLA, the faculty included Noelia Sabater Cruz, MD; Zoraida Del Campo, MD; Antonio Verdejo, DO, MSc; David Piñero, OD, PhD; Javi Rojas, OD; Javier Sebastián Carmona, DOO; Epifanio Ruiz Campos, DOO, GOO; Juan Bolívar Parra, DOO, FIAOMC, IACMM; and Jessica Costa, Máster en Optometría.

FitAcademy Spain

 

 

 

About Conóptica
Conoptica has more than 55 years of experience in the contact lens and optometry industry. The company provides products, services, and education to eye care professionals to provide effective and tailored visual solutions. Learn more at https://www.conoptica.es/es/

 

About BostonSight®
BostonSight is a nonprofit eye healthcare organization that advances the treatment of irregular corneas and ocular surface disease through specialty lenses. Our ongoing commitment to research and achieving optimal patient outcomes via innovative specialty lens designs, education, and technology has saved the sight of thousands of people around the world. Learn more at www.bostonsight.org

https://www.bostonsight.org/wp-content/uploads/2026/06/Conoptica-Logo-White-Background-1200x558-1.jpg 558 1200 michele /wp-content/uploads/2026/05/bostonsight-logo.svg michele2025-12-10 13:45:432026-06-18 11:12:12BostonSight Expands to Europe with BostonSight SCLERAL and FitAcademy

Pages

  • About
  • Clinical Trials and R&D Services
  • Conditions We Treat
  • Contact Us
  • Dry Eye
  • Education
  • Find a PROSE Clinic
  • FitAcademy
  • FitAcademy for Residents
  • FitAcademy Immersive
  • FitAcademy International
  • GVHD
  • Home
  • Keratoconus
  • Manufacturing
  • Needham PROSE Clinic
  • News
  • Notice of Privacy Practices for Patients
  • Ophthalmology Resident Lectures
  • Our Approach
  • Our Partners
  • Our People
  • Our Products
  • Patient Care
  • Patient Information Booklet
  • Patient Resources
  • Patient Stories
  • Pediatrics
  • Post-Corneal Transplant
  • Post-LASIK
  • Practitioner IFU
  • Privacy Policy
  • PROSE Provider Payment Form
  • PROSE Treatment
  • Publications
  • Research
  • Research Studies
  • Sjögren’s Disease
  • Software Platforms
  • Stevens-Johnson Syndrome
  • Technology
  • Terms of Use
  • Visiting Clinicians
  • Ways to Support Us

Categories

  • Blog Posts
  • Clinic Updates
  • In the Media
  • Patient Stories
  • Press Release
  • PROSE
  • SCLERAL

Archive

  • May 2026
  • April 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • July 2025
  • June 2025
  • May 2025
  • January 2025
  • November 2024
  • October 2024
  • September 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • July 2023
  • May 2023
  • March 2023
  • February 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • March 2020
  • Patient Care
    • PROSE Treatment
    • Find a PROSE Clinic
    • Conditions We Treat
    • Patient Stories
    • Patient Resources
    • Pediatrics
  • Technology
    • Our Products
    • Software Platforms
    • Manufacturing Lab
  • Education
    • Visiting Clinicians
    • FitAcademy International
    • FitAcademy for Residents
    • FitAcademy Immersive
    • Ophthalmology Resident Lectures
  • Research
    • Clinical Trials and R&D Services
    • Research Studies
    • Publications
  • About
    • Our Approach
    • News
    • Our People
    • Partners
  • Needham PROSE Clinic
  • Donate
  • Contact Us

© 2026 BostonSight. All rights reserved.

Privacy PolicyTerms of Use

Scroll to top Scroll to top Scroll to top
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings ACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non Necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

Save & Accept